Globus Medical, Inc. (FRA:GM0N)

Market Cap	10.22B -14.8%
Revenue (ttm)	2.36B +11.7%
Net Income	361.19M +363.1%
EPS	2.62 +358.9%
Shares Out	n/a
PE Ratio	28.28
Forward PE	21.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	16
Open	79.50
Previous Close	80.00
Day's Range	79.50 - 79.50
52-Week Range	44.40 - 90.50
Beta	n/a
RSI	43.66
Earnings Date	Feb 24, 2026

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip a...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 5,300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GM0N

Financial Performance

In 2024, Globus Medical's revenue was $2.52 billion, an increase of 60.62% compared to the previous year's $1.57 billion. Earnings were $102.98 million, a decrease of -16.19%.

Financial numbers in USD